Home/ Supplements/ Electrolytes/ Ningxia Red

Ningxia Red

product on market Liquid Young Living Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Ningxia Red
Open Full PDF View on NIH DSLD →
Details

Label Data

59 mL
Serving Size
12.5
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Total Carbohydrates
6 Gram(s) (2% DV)
Protein
1 Gram(s)
Calcium
40 mg (4% DV)
Iron
0.4 mg (2% DV)
Sodium
35 mg (2% DV)
NingXia Red Blend
58 Gram(s)
Essential Oil Blend
100 mg

Other Ingredients

Water Tartaric Acid natural Blueberry flavor pure Vanilla extract Malic Acid Pectin Sodium Benzoate Stevia rebaudiana extract
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Drink 2 fl. oz. 1-2 times daily. Best served chilled. Shake well before use. Refrigerate after opening and consume within 30 days.

Warnings & Precautions

Do not drink directly from the bottle. Do not use if safety seal is broken.

Caution: Keep out of reach of children.

If you are pregnant, nursing, taking medication, or have a medical condition, consult a health care professional prior to use.

Formulation Notes

Ningxia Red combines the extraordinary wolfberry superfruit with 100% pure essential oils in a powerful, whole-body nutrient infusion. The benefits of the legendary Ningxia wolfberry have been sought after for centuries, and ongoing research continues to yield exciting, new health properties.

Enjoy its naturally delicious flavor daily to sustain energy and to fortify and replenish key nutrients for long-lasting health and wellness.

100% pure, therapeutic-grade essential oil

Additional Information

Energize Fortify Revitalize

Refrigerate after opening and consume within 30 days.

Storage: Keep in a cool, dark place.

Formulated by D. Gary Young

Metadata

Product Details

DSLD Entry Date2022-08-23
Product TypeBotanical
FormLiquid
DSLD ID273811
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.